Stockreport

Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

Pyxis Oncology, Inc.  (PYXS) 
PDF Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first quarter of 2026 Updated data from MICVO Phase 1 monotherapy study in 2L+ R/M HNSCC on track for mid-year [Read more]